Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | LDHB | P07195 | 1/20 | 0.38 |
| ▸ | HAO1 | Q9UJM8 | 14/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6474736 | 0.98 | LDHA (0.37) | LDHALDHBHAO1HCAR2CYP1A2 | |
| SCHEMBL12050686 | 0.84 | HAO1 (0.35) | HAO1 | |
| Biguanide SCHEMBL28474366 | 0.83 | HAO1 (0.31) | HAO1 | |
| SCHEMBL2385273 | 0.79 | KDM4C (0.46) | HAO1HCAR2MAPK1 | |
| SCHEMBL5185712 | 0.79 | KDM4C (0.46) | HAO1MAPK1 | |
| SCHEMBL12050672 | 0.75 | — | — | |
| SCHEMBL6404716 | 0.75 | — | — | |
| SCHEMBL14672695 | 0.75 | KDM5A (0.36) | HCAR2MAPK1PIN1 | |
| SCHEMBL28728618 | 0.73 | HAO1 (0.47) | HAO1 | |
| SCHEMBL24310439 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735559-A | MOF-based alkaline earth metal phosphorescent material and preparation method and application thereof | 河南地矿职业学院 | 2025-04-01 | — | — | CN | claimed |
| CN-119409649-A | Synthesis method of 1,2, 3-triazole-4, 5-dicarboxylic acid | 山西新天源药业有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118878471-A | Continuous preparation method and system of 1H-1,2, 3-triazole | 青岛科技大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118638092-A | Preparation method of glycerol ketal | 浙江博聚新材料有限公司 | 2024-09-13 | — | — | CN | claimed |
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | COBIORES NV (BE) | 2024-04-18 | — | — | US | claimed |
| US-11932765-B2 | Meltable intumescent flame retardant compositions | QED LABS, INC. (US) | 2024-03-19 | — | — | US | claimed |
| CN-116947769-A | Preparation method of 1H-1,2, 3-triazole | 江西祥太生命科学有限公司 | 2023-10-27 | — | — | CN | claimed |
| US-20230331986-A1 | MELTABLE INTUMESCENT FLAME RETARDANT COMPOSITIONS | QED LABS INC (US) | 2023-10-19 | — | — | US | claimed |
| CN-114805839-B | Ultraviolet wavelength detection material based on coordination polymer and application thereof | 南开大学 | 2023-08-18 | — | — | CN | claimed |
| EP-4054739-A1 | REGENERABLE VOC FILTERS WITH IMPROVED SELECTIVITY AND EFFICACY | Ecole Nationale Supérieure d'Ingénieurs de Caen (FR) | 2022-09-14 | — | — | EP | claimed |
| WO-2001095943-A2 | PRODRUG COMPOUNDS WITH AN OLIGOPEPTIDE HAVING AN ISOLEUCINE RESIDUE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| WO-2001095945-A2 | PRODRUG COMPOUNDS CLEAVABLE BY THIMET OLIGOPEPTIDASE | MEDAREX, INC. (US) | 2001-12-20 | — | — | WO | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| EP-0998481-A1 | PHOTOSENSITIZERS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2000-05-10 | — | — | EP | claimed |
| WO-1999003868-A1 | PHOTOSENSITIZERS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1999-01-28 | — | — | WO | claimed |
| US-5659348-A | APPLYING TO A SUBSTRATE | XEROX CORPORATION (US) | 1997-08-19 | — | — | US | claimed |
| WO-1997027360-A1 | PHASE SEPARATION APPARATUS | SCAPA GROUP PLC (GB) | 1997-07-31 | — | — | WO | claimed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-4810397-A | ALUMINUM COMPOUND, ACID, THIADIAZOLE OR TRIAZOLE | UNION OIL COMPANY OF CALIFORNIA (US) | 1989-03-07 | — | — | US | claimed |
| US-4719001-A | ALUMINUM COMPOUND AND THIADIAZOLE DERIVATIVE | UNION OIL COMPANY OF CALIFORNIA (US) | 1988-01-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | ALG8, ALG1, LNPEP | LDHA 755/4885LDHB 897/4885HAO1 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.